Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Stopped early

Conditions studied: Cutaneous Lymphoma, Other Skin Disorders, Mycosis Fungoides, Cutaneous T-cell Lymphoma

In brief

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Key facts

Study ID

NCT01556828

Run by

Stanford University

People needed

70

Starts

2011-06-01

Expected to finish

2014-06-01

Last updated by the study team

2016-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 18 years of age or older
• Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic disorder being examined.
• Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

You may not qualify if…

• Less than 18 years of age

Where it is running

• Stanford University, School of Medicine — Stanford, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.